The FDA cleared DigniCap Scalp Cooling System minimises hair loss from chemotherapy in patients with solid tumours.
The agreement provides the opportunity for any of the 45 AON locations to easily provide DigniCap Scalp Cooling for their patients.
AON is medical oncology provider with a focus on supporting the long-term viability of oncology treatment in community-based settings. AON currently serves an expanding network of partner practices across 12 states, providing dedicated end-to-end administrative support, access to an extensive array of centralized ancillary services, and proven practice management expertise.
AON CEO Brad Prechtl, said: “This partnership with Dignitana enables us to improve the patient experience. Our physicians are committed to providing exceptional cancer care. By being able to offer DigniCap to patients undergoing chemotherapy, we’ll be helping to diminish the added emotional burden from hair loss.”
William Cronin, chief executive officer of Dignitana AB, said: “AON provides a unique model of physician-led community oncology that aligns well with our organisational goals. Physicians know that hair loss is a significant quality of life issue and they want to provide DigniCap for their patients. This master contract expedites the administrative process so that more patients can access this life-changing therapy.”
The DigniCap Scalp Cooling System is available at over 160 locations in 30 states in the U.S. and in 38 markets globally.